APA (7th ed.) Citation

Li, H., Lin, S., Wang, Y., Chen, L., Zheng, X., & Wei, L. (2024). Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus. Microbiology Spectrum, 12(11), . https://doi.org/10.1128/spectrum.01276-24

Chicago Style (17th ed.) Citation

Li, He-Jun, Shu-Huan Lin, Yan-Qing Wang, Ling Chen, Xiang-Xiong Zheng, and Li-Xin Wei. "Cyclosporine May Reduce the Risk of Symptomatic COVID-19 in Patients with Systemic Lupus Erythematosus." Microbiology Spectrum 12, no. 11 (2024). https://doi.org/10.1128/spectrum.01276-24.

MLA (9th ed.) Citation

Li, He-Jun, et al. "Cyclosporine May Reduce the Risk of Symptomatic COVID-19 in Patients with Systemic Lupus Erythematosus." Microbiology Spectrum, vol. 12, no. 11, 2024, https://doi.org/10.1128/spectrum.01276-24.